Show simple item record

dc.contributor.authorAlías-Ferri, María
dc.contributor.authorGarcía-Marchena, Nuria
dc.contributor.authorMestre-Pintó, Joan
dc.contributor.authorAraos, Pedro
dc.contributor.authorVergara Moragues, Esperanza 
dc.contributor.authorFonseca, Francina
dc.contributor.authorGonzález Saiz, Francisco Manuel 
dc.contributor.authorRodríguez de Fonseca, Fernando
dc.contributor.authorTorrens, Marta
dc.contributor.authorNEURODEP, Group
dc.contributor.otherNeurocienciases_ES
dc.contributor.otherPsicologíaes_ES
dc.date.accessioned2024-09-02T08:38:16Z
dc.date.available2024-09-02T08:38:16Z
dc.date.issued2021
dc.identifier.issn0214-4840
dc.identifier.urihttp://hdl.handle.net/10498/33106
dc.description.abstractBackground: Cocaine use is a growing global health problem and patients with cocaine use disorders (CUD) present several complications, including high rates of major depression. These subjects present two types of major depressive disorder (MDD): primary major depressive disorder (P-MDD) and cocaine-induced major depressive disorder (CI-MDD). To improve treatment, it is necessary to distinguish between both types. The aim of this study was to assess the differences in depressive symptomatology criteria (P-MDD vs CI-MDD) in CUD patients. Methods: Secondary data analysis was carried out with a cross-sectional sample of 160 patients presenting CUD and MDD. Clinical assessment was performed using the Psychiatric Research Interview for Substance and Mental Disorders (PRISM). A differential diagnosis was obtained between P-MDD and CI-MDD. Results: Men represented 80% of the sample, the mean age was 38.61 years, and 64.5% had elementary studies. CI-MDD diagnosis (61.3%) was more frequent than P-MDD (38.7%). There was a younger age of CUD onset in CI-MDD patients. In addition, 79.4% of the patients had another substance use disorder diagnosis. The criterion "Changes in weight or appetite" was more prevalent (57.1%) in P-MDD group. Conclusions: We found differences in the criterion "Changes in weight or appetite". Further research is needed in this field to establish a differential diagnosis and thus provide better treatment for CUD patients.es_ES
dc.formatapplication/pdfes_ES
dc.language.isoenges_ES
dc.sourceAlías-Ferri, M. García-Marchena, N, Mestre-Pinto, JI, Araos, P, Vergara-Moragues, E; Fonseca, F, González-Saiz, F, Rodríguez de Fonseca, F, Torrens, M & NEURODEP Group. (2021). Cocaine and depressive disorders: when standard clinical diagnosis is insufficient. Adicciones 33(3),193-199. doi: 10.20882/adicciones.1321es_ES
dc.subjectDual diagnosises_ES
dc.subjectcocaine use disorderes_ES
dc.subjectcocaine-related disorderses_ES
dc.subjectdepressive disorderes_ES
dc.subjectinduced depressiones_ES
dc.titleCocaine and depressive disorders: When standard clinical diagnosis is insufficientes_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.20882/adicciones.1321
dc.type.hasVersionVoRes_ES


Files in this item

This item appears in the following Collection(s)

Show simple item record